AIMS/HYPOTHESIS: Rare mutations in the gene HNF4A, encoding the transcription factor hepatocyte nuclear factor 4α (HNF-4A), account for ~5% of cases of MODY and more frequent variants in this gene may be involved in multifactorial forms of diabetes. Two low-frequency, non-synonymous variants in HNF4A (V255M, minor allele frequency [MAF] ~0.1%; T130I, MAF ~3.0%)-known to influence downstream HNF-4A target gene expression-are of interest, but previous type 2 diabetes association reports were inconclusive. We aimed to evaluate the contribution of these variants to type 2 diabetes susceptibility through large-scale association analysis. METHODS: We genotyped both variants in at least 5,745 cases and 14,756 population controls from the UK and Denmark. We also undertook an expanded association analysis that included previously reported and novel genotype data obtained in Danish, Finnish, Canadian and Swedish samples. A meta-analysis incorporating all published association studies of the T130I variant was subsequently carried out in a maximum sample size of 14,279 cases and 26,835 controls. RESULTS: We found no association between V255M and type 2 diabetes in either the initial (p = 0.28) or the expanded analysis (p = 0.44). However, T130I demonstrated a modest association with type 2 diabetes in the UK and Danish samples (additive per allele OR 1.17 [95% CI 1.08-1.28]; p = 1.5 × 10⁻⁴), which was strengthened in the meta-analysis (OR 1.20 [95% CI 1.10-1.30]; p = 2.1 × 10⁻⁵). CONCLUSIONS/ INTERPRETATION: Our data are consistent with T130I as a low-frequency variant influencing type 2 diabetes risk, but are not conclusive when judged against stringent standards for genome-wide significance. This study exemplifies the difficulties encountered in association testing of low-frequency variants.
AIMS/HYPOTHESIS: Rare mutations in the gene HNF4A, encoding the transcription factor hepatocyte nuclear factor 4α (HNF-4A), account for ~5% of cases of MODY and more frequent variants in this gene may be involved in multifactorial forms of diabetes. Two low-frequency, non-synonymous variants in HNF4A (V255M, minor allele frequency [MAF] ~0.1%; T130I, MAF ~3.0%)-known to influence downstream HNF-4A target gene expression-are of interest, but previous type 2 diabetes association reports were inconclusive. We aimed to evaluate the contribution of these variants to type 2 diabetes susceptibility through large-scale association analysis. METHODS: We genotyped both variants in at least 5,745 cases and 14,756 population controls from the UK and Denmark. We also undertook an expanded association analysis that included previously reported and novel genotype data obtained in Danish, Finnish, Canadian and Swedish samples. A meta-analysis incorporating all published association studies of the T130I variant was subsequently carried out in a maximum sample size of 14,279 cases and 26,835 controls. RESULTS: We found no association between V255M and type 2 diabetes in either the initial (p = 0.28) or the expanded analysis (p = 0.44). However, T130I demonstrated a modest association with type 2 diabetes in the UK and Danish samples (additive per allele OR 1.17 [95% CI 1.08-1.28]; p = 1.5 × 10⁻⁴), which was strengthened in the meta-analysis (OR 1.20 [95% CI 1.10-1.30]; p = 2.1 × 10⁻⁵). CONCLUSIONS/ INTERPRETATION: Our data are consistent with T130I as a low-frequency variant influencing type 2 diabetes risk, but are not conclusive when judged against stringent standards for genome-wide significance. This study exemplifies the difficulties encountered in association testing of low-frequency variants.
Authors: S Wiltshire; A T Hattersley; G A Hitman; M Walker; J C Levy; M Sampson; S O'Rahilly; T M Frayling; J I Bell; G M Lathrop; A Bennett; R Dhillon; C Fletcher; C J Groves; E Jones; P Prestwich; N Simecek; P V Rao; M Wishart; G F Bottazzo; R Foxon; S Howell; D Smedley; L R Cardon; S Menzel; M I McCarthy Journal: Am J Hum Genet Date: 2001-08-01 Impact factor: 11.025
Authors: Q Zhu; K Yamagata; A Miura; N Shihara; Y Horikawa; J Takeda; J Miyagawa; Y Matsuzawa Journal: Diabetologia Date: 2003-03-25 Impact factor: 10.122
Authors: James Rhee; Yusuke Inoue; J Cliff Yoon; Pere Puigserver; Melina Fan; Frank J Gonzalez; Bruce M Spiegelman Journal: Proc Natl Acad Sci U S A Date: 2003-03-21 Impact factor: 11.205
Authors: Latisha D Love-Gregory; Jonathon Wasson; Jiyan Ma; Carol H Jin; Benjamin Glaser; Brian K Suarez; M Alan Permutt Journal: Diabetes Date: 2004-04 Impact factor: 9.461
Authors: Hana Lango; Colin N A Palmer; Andrew D Morris; Eleftheria Zeggini; Andrew T Hattersley; Mark I McCarthy; Timothy M Frayling; Michael N Weedon Journal: Diabetes Date: 2008-06-30 Impact factor: 9.461
Authors: Sekar Kathiresan; Cristen J Willer; Gina M Peloso; Serkalem Demissie; Kiran Musunuru; Eric E Schadt; Lee Kaplan; Derrick Bennett; Yun Li; Toshiko Tanaka; Benjamin F Voight; Lori L Bonnycastle; Anne U Jackson; Gabriel Crawford; Aarti Surti; Candace Guiducci; Noel P Burtt; Sarah Parish; Robert Clarke; Diana Zelenika; Kari A Kubalanza; Mario A Morken; Laura J Scott; Heather M Stringham; Pilar Galan; Amy J Swift; Johanna Kuusisto; Richard N Bergman; Jouko Sundvall; Markku Laakso; Luigi Ferrucci; Paul Scheet; Serena Sanna; Manuela Uda; Qiong Yang; Kathryn L Lunetta; Josée Dupuis; Paul I W de Bakker; Christopher J O'Donnell; John C Chambers; Jaspal S Kooner; Serge Hercberg; Pierre Meneton; Edward G Lakatta; Angelo Scuteri; David Schlessinger; Jaakko Tuomilehto; Francis S Collins; Leif Groop; David Altshuler; Rory Collins; G Mark Lathrop; Olle Melander; Veikko Salomaa; Leena Peltonen; Marju Orho-Melander; Jose M Ordovas; Michael Boehnke; Gonçalo R Abecasis; Karen L Mohlke; L Adrienne Cupples Journal: Nat Genet Date: 2008-12-07 Impact factor: 38.330
Authors: M A Granados-Silvestre; M G Ortiz-López; J Granados; S Canizales-Quinteros; Rosenda I Peñaloza-Espinosa; C Lechuga; V Acuña-Alonzo; K Sánchez-Pozos; M Menjivar Journal: Mol Genet Genomics Date: 2017-07-07 Impact factor: 3.291
Authors: Jacklyn N Hellwege; Pamela J Hicks; Nicholette D Palmer; Maggie C Y Ng; Barry I Freedman; Donald W Bowden Journal: J Diabetes Metab Date: 2011-10-20
Authors: Anup K Nair; Paolo Piaggi; Nellie A McLean; Manmeet Kaur; Sayuko Kobes; William C Knowler; Clifton Bogardus; Robert L Hanson; Leslie J Baier Journal: Diabetologia Date: 2015-12-15 Impact factor: 10.122
Authors: Thomas W Laver; Kevin Colclough; Maggie Shepherd; Kashyap Patel; Jayne A L Houghton; Petra Dusatkova; Stepanka Pruhova; Andrew D Morris; Colin N Palmer; Mark I McCarthy; Sian Ellard; Andrew T Hattersley; Michael N Weedon Journal: Diabetes Date: 2016-08-02 Impact factor: 9.461
Authors: L D Tientcheu; J Maertzdorf; J Weiner; I M Adetifa; H-J Mollenkopf; J S Sutherland; S Donkor; B Kampmann; S H E Kaufmann; H M Dockrell; M O Ota Journal: Genes Immun Date: 2015-06-04 Impact factor: 2.676
Authors: Jane F Ferguson; Gregory J Matthews; Raymond R Townsend; Dominic S Raj; Peter A Kanetsky; Matthew Budoff; Michael J Fischer; Sylvia E Rosas; Radhika Kanthety; Mahboob Rahman; Stephen R Master; Atif Qasim; Mingyao Li; Nehal N Mehta; Haiqing Shen; Braxton D Mitchell; Jeffrey R O'Connell; Alan R Shuldiner; Weang Kee Ho; Robin Young; Asif Rasheed; John Danesh; Jiang He; John W Kusek; Akinlolu O Ojo; John Flack; Alan S Go; Crystal A Gadegbeku; Jackson T Wright; Danish Saleheen; Harold I Feldman; Daniel J Rader; Andrea S Foulkes; Muredach P Reilly Journal: J Am Coll Cardiol Date: 2013-05-30 Impact factor: 24.094